A Review of Methods used to Quantify Effect Sizes in Clinical Trials

Slides:



Advertisements
Similar presentations
How to write a study protocol Hanne-Merete Eriksen (based on Epiet 2004)
Advertisements

Protocol Development.
Introducing... Reproduced and modified from a presentation produced by Zoë Debenham from the original presentation created by Kate Light, Cochrane Trainer.
Structural uncertainty from an economists’ perspective
Sample size calculations
Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review Journal club presentation
Identifying evidence for decision-analytic models Suzy Paisley DoH Research Scientist in Evidence Synthesis Consensus Working Group on the Use of Evidence.
Guidelines for the reporting of evidence identification in decision models: observations and suggested way forward Louise Longworth National Institute.
Are the results valid? Was the validity of the included studies appraised?
What is a research proposal? Plan to test hypothesis using research Write research Proposal (plan) Carry out research Apply for grant/ethics Clinical.
Systematic Reviews.
Title Name Institute. Background -1 (Main problem)
Evidence Based Medicine Meta-analysis and systematic reviews Ross Lawrenson.
EBC course 10 April 2003 Critical Appraisal of the Clinical Literature: The Big Picture Cynthia R. Long, PhD Associate Professor Palmer Center for Chiropractic.
Plymouth Health Community NICE Guidance Implementation Group Workshop Two: Debriding agents and specialist wound care clinics. Pressure ulcer risk assessment.
The (ab)use of symptom scores in asthma clinical trials: a systematic review Geoff Frampton & Jonathan Shepherd Southampton Health Technology Assessments.
Developing a Review Protocol. 1. Title Registration 2. Protocol 3. Complete Review Components of the C2 Review Process.
META-ANALYSIS, RESEARCH SYNTHESES AND SYSTEMATIC REVIEWS © LOUIS COHEN, LAWRENCE MANION & KEITH MORRISON.
Sifting through the evidence Sarah Fradsham. Types of Evidence Primary Literature Observational studies Case Report Case Series Case Control Study Cohort.
EBM --- Journal Reading Presenter :呂宥達 Date : 2005/10/27.
Pilot and Feasibility Studies NIHR Research Design Service Sam Norton, Liz Steed, Lauren Bell.
Systematic reviews and meta-analyses: when and how to do them Andrew Smith Royal Lancaster Infirmary 18 May 2015.
Evidence Based Practice (EBP) Riphah College of Rehabilitation Sciences(RCRS) Riphah International University Islamabad.
NIHR using systematic reviews to inform funding decisions Matt Westmore, Director of Finance and Strategy Sheetal Bhurke, Research Fellow NIHR Evaluation,
Research proposal (Lecture 3) Dr.Rehab F Gwada. Objectives of the Lecture The student at the end of this lecture should Know Identify Target Population.
Developing a proposal Dónal O’Mathúna, PhD Senior Lecturer in Ethics, Decision-Making & Evidence
Remaining Challenges in Assessing Non-Inferiority Steven Snapinn DIA Statistics Community Virtual Journal Club December 16, 2014 Based on Paper with Qi.
VALIDITY What is validity? What are the types of validity? How do you assess validity? How do you improve validity?
Analytical Interventional Studies
A systematic review of selected journals
Title Investigators and sites. Clinical Trial Proposal Presentation Template for open forum at the 2017 ASM.
Sample Size Determination
What size of trial do I need?
Kylie Lange, CRE Biostatistician
DATA COLLECTION METHODS IN NURSING RESEARCH
Do Adoptees Have Lower Self Esteem?
Brady Et Al., "sequential compression device compliance in postoperative obstetrics and gynecology patients", obstetrics and gynecology, vol. 125, no.
Performance Improvement Project Validation Process Outcome Focused Scoring Methodology and Critical Analysis Presenter: Christi Melendez, RN, CPHQ Associate.
Evidence-based Medicine
The DELTA2 Study: Summary of Methodology and Results
Gian Luca Di Tanna Vladislav Berdunov Richard Hooper
How to write a study protocol
Writing research and grant applications – from idea to submission
Confidence Intervals and p-values
Supplementary Table 1. PRISMA checklist
Deputy Director, Division of Biostatistics No Conflict of Interest
Randomized Trials: A Brief Overview
Clinical Study Results Publication
Performance Improvement Project Validation Process Outcome Focused Scoring Methodology and Critical Analysis Presenter: Christi Melendez, RN, CPHQ Associate.
Strategies to incorporate pharmacoeconomics into pharmacotherapy
Nicola Totton Bangor University
AXIS critical Appraisal of cross sectional Studies
Chapter 7 The Hierarchy of Evidence
H676 Meta-Analysis Brian Flay WEEK 1 Fall 2016 Thursdays 4-6:50
Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES study Jelena Savović1, Becky Turner2, David.
11/20/2018 Study Types.
Pilot Studies: What we need to know
CLINICAL RESEARCH: An Introduction
A comparison between North and South of Europe
How EBM brings the connection between evidence and measurement into focus. Benjamin Smart.
Dr Peter Groves MD FRCP Consultant Cardiologist
Dr. Matthew Keough August 8th, 2018 Summer School
Dr. Maryam Tajvar Department of Health Management and Economics
Dr. Maryam Tajvar Department of Health Management and Economics
EAST GRADE course 2019 Introduction to Meta-Analysis
Professor of Health Economics
Meta-analysis, systematic reviews and research syntheses
Introduction to Research Romulo S. de Villa, MD, PhD, Cert. Biochemistry Molecular & Nutritional Oncologist Professor of Biochemistry & Nutrition Molecular.
Aparna Raychaudhuri, Ph. D
A Meta-analysis of the effect of medicated health communication campaigns Trent C. Joseph PCH 586.
Presentation transcript:

A Review of Methods used to Quantify Effect Sizes in Clinical Trials Joanne Rothwell University of Sheffield PSI Conference, London, May 2017

PSI Conference, London, May 2017 Outline Aims of Research Methods Results Limitations Further Work PSI Conference, London, May 2017

PSI Conference, London, May 2017 Aims of Research To investigate: which methods are commonly used and reported for eliciting the target effect size how “accurate” the target effect size is compared to the observed effect size whether particular clinical areas are consistently over- or under-achieving the target effect size examples of well-justified sample size calculations and target effect size elicitation. To be completed. PSI Conference, London, May 2017

PSI Conference, London, May 2017 Aims of Research Standard sample size formula for superiority trials Fixed Most sensitive variable As Steven mentioned Estimated PSI Conference, London, May 2017

PSI Conference, London, May 2017 Aims of Research Standard sample size formula for superiority trials Fixed If d is halved, the sample size quadruples Estimated PSI Conference, London, May 2017

PSI Conference, London, May 2017 Methods Why is this research useful? It would be interesting to know which methods are most commonly used to elicit the target difference and which are most reported. This would be useful for the DELTA2 guidance. It would be useful to know how many studies are not observing a difference close to the target difference which the study was originally powered on. PSI Conference, London, May 2017

PSI Conference, London, May 2017 Methods How was this research completed? Review the Health Technology Assessment (HTA) reports for randomised controlled trials Extract data from the reports over the period 2006-2016 HTA used because they are the main public funder in the UK PSI Conference, London, May 2017

Inclusion/Exclusion Criteria for Reports Extracted variables included: Target and observed effect size, target and achieved sample size, elicitation method (if reported), clinical area, outcome measure, target power. Exclusion based on initial title and abstract reading: systematic reviews (most common X%), literature reviews, feasibility and pilot studies, observational studies, cost-effectiveness and decision analysis. Once extraction commenced, other exclusions were required: factorial trials (no clear target difference or elicitation appeared), non-inferiority studies (no target difference, based on NI margin), equivalence studies (again, based on equivalence margin), vaccination trials (Hard to extract all relevant information from these). PSI Conference, London, May 2017

Report Selection PSI Conference, London, May 2017 994 reports (107 RCT reports since 5 reports document two RCTs in one report.)   684 reports 310 reports excluded: Published before 2006 75 reports excluded: 9 Factorial trials 5 Non-inferiority trials 10 Equivalence trials 20 Cluster Trials 19 reports not RCTs 1 Cross-over trial 11 Too difficult to extract or not enough information provided 177 reports 507 reports excluded: Not RCTs PSI Conference, London, May 2017

Total Number of Reports General Results Volume Year Total Number of Reports Included RCTs 20 2016 95 19 2015 102 18 2014 71 12 17 2013 61 11 16 2012 49 8 15 2011 45 6 14 2010 60 13 2009 62 10 2008 36 2 2007 53 3 2006 50 Total 684 107 PSI Conference, London, May 2017

Elicitation Categories 7 categories based on DELTA publication (Cook et al. 2014) [1] Anchor method Distribution method Health Economic method Opinion-seeking method Pilot-study method Review of evidence base method Standardised effect size method Jonathan will define these more formally later. I'm sure many of you have used one or a combination of these methods to elicit a target effect size. PSI Conference, London, May 2017

Study Characteristics Most common Clinical Area Mental Health (16.7%) Setting Hospital (51%) Elicitation Methods Review of Evidence Base (46%) PSI Conference, London, May 2017

PSI Conference, London, May 2017 General Results PSI Conference, London, May 2017

PSI Conference, London, May 2017 General Results PSI Conference, London, May 2017

PSI Conference, London, May 2017 General Results PSI Conference, London, May 2017

PSI Conference, London, May 2017 General Results Shows that most common method across all the clinical areas is using previous research These elicitation categories are ones which contain slightly more detail than the condensed DELTA categories. This shows that across all clinical areas previous research is most commonly used to eliciti the target difference. PSI Conference, London, May 2017

PSI Conference, London, May 2017 General Results Using DELTA categories, most common method is consistently Review of Evidence Using the DELTA categories, it is clear to see that the Review of Evidence method (using previous research) comes out on top as the most common method, particularly in Mental health. PSI Conference, London, May 2017

Estimated/Target Standardised Effect Size Smallest Target Effect sizes Largest Target Effect sizes PSI Conference, London, May 2017

Estimated/Target Standardised Effect Size Smallest Target Effect sizes Seems very large Largest Target Effect sizes PSI Conference, London, May 2017

Estimated/Target Standardised Effect Size Smallest Target Effect sizes Large variation Whilst this could be due to different interventions, it is still interesting to see. Largest Target Effect sizes PSI Conference, London, May 2017

Estimated vs Observed Standardised Effect Size General relationship - Estimated SES are higher than Observed It would be expected for the protocol to have a higher expected/target effect size than observed, as half of all publicly fundedtrials are not statistically significant. PSI Conference, London, May 2017

Estimated vs Observed Standardised Effect Size General relationship - Estimated SES are higher than Observed. As predicted PSI Conference, London, May 2017

Estimated vs Observed Standardised Effect Size Very high observed effect size - Renal/Urology study. p<0.001 PSI Conference, London, May 2017

PSI Conference, London, May 2017 Limitations Only one reviewer, 177 reports to read through and 102 to extract information from. No QA available Some reports difficult to extract from due to unclear sample size justifications In order to compare effect sizes for clinical categories, categories may need to be combined. This needs consultation with a clinical expert. Only one reviewer. PSI Conference, London, May 2017

PSI Conference, London, May 2017 Summary Mental Health is most commonly published clinical area for RCTs. Most common method of elicitation is using previous research or a combination of various methods including a review of the evidence. (49%) Target effect sizes are typically larger than observed effect sizes (this is as expected) Only one reviewer. PSI Conference, London, May 2017

PSI Conference, London, May 2017 References JA Cook, J Hislop, TE Adewuyi, K Harrild, DG Altman, CR Ramsay, C Fraser, B Buckley, P Fayers, I Harvey, AH Briggs, JDNorrie, D Fergusson, I Ford, LD Vale. Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls). Health Technology Assessment 18(28), 2014 Only one reviewer. PSI Conference, London, May 2017

Thank you for your attention. ? ? ? Any Questions? ? Only one reviewer. PSI Conference, London, May 2017